Stock ARYA ARYA SCIENCES ACQUISITION III A
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

ARYA Sciences Acquisition III A

Equities

ARYA

KYG3166W1069

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about ARYA Sciences Acquisition III A

ARYA Sciences Acquisition Corp III(NasdaqCM:ARYA) dropped from NASDAQ Composite Index CI
Nautilus Biotechnology, Inc. completed the acquisition of ARYA Sciences Acquisition Corp III in a reverse merger transaction. CI
Arya Sciences Acquisition Corp Iii Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Arya Sciences Acquisition Corp Iii Reports Earnings Results for the Nine Months Ended December 31, 2020 CI
Close Update: US Stocks End With New Highs on Stimulus Support From Yellen, Continued Vaccine Deployment MT
Sector Update: Health Care Stocks Sit Out Monday Markets Rise Despite Biotech Gains MT
Update: Arya Sciences Acquisition III Shares Almost Double After Unveiling Merger Agreement With Nautilus Biotechnology MT
Sector Update: Health Care Stocks Edging Lower Despite Solid Gains for Biotechs MT
US Stocks Advance, Oil Jumps After Treasury Secretary Reinforces Backing for Big US Fiscal Stimulus Plans MT
Midday Report: US Stocks Advance, Oil Jumps After Treasury Secretary Reinforces Backing for Big US Fiscal Stimulus Plans MT
ARYA Sciences Acquisition III : Nautilus Biotechnology to Combine with Blank-Check Firm Arya Sciences MT
DJ Industrial : Wall Street Set for Small Gains, Buoyed by Stimulus Progress MT
Nautilus Biotechnology, Inc. entered into a definitive merger agreement to acquire ARYA Sciences Acquisition Corp III for approximately $1 billion in a reverse merger transaction. CI
Certain Class B Ordinary Shares of ARYA Sciences Acquisition Corp III are subject to a Lock-Up Agreement Ending on 3-FEB-2021. CI
ARYA Sciences Acquisition Corp III announced that it has received $4.99 million in funding from Arya Sciences Holdings III CI
ARYA Sciences Acquisition Corp III(NasdaqCM:ARYA) added to NASDAQ Composite Index CI
ARYA Sciences Acquisition Corp III has completed an IPO in the amount of $130 million. CI
ARYA Sciences Acquisition Corp III has filed an IPO in the amount of $125 million. CI
ARYA Sciences Acquisition Corp III announced that it expects to receive $4.5 million in funding from Arya Sciences Holdings III CI

Chart ARYA Sciences Acquisition III A

Chart ARYA Sciences Acquisition III A
More charts

Company Profile

ARYA Sciences Acquisition Corp III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. It intends to focus on entities operating in the healthcare industry, particularly the life sciences and medical technology sectors. It has not commenced any operations.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. ARYA Stock
  4. News ARYA Sciences Acquisition III A
  5. Update: Arya Sciences Acquisition III Shares Almost Double After Unveiling Merger Agreement With Nautilus Biotechnology